Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2013
03/27/2013CN101296907B Diaminopyrimidines as P2X3 and P2X2/3 modulators
03/27/2013CN101287721B 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use
03/27/2013CN101273029B Bicyclic bisamide derivatives and use thereof as insecticides
03/27/2013CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors
03/26/2013US8404852 Gyrase inhibitors and uses thereof
03/26/2013US8404837 Quinoline derivatives as P13 kinase inhibitors
03/26/2013US8404765 Sterically hindered amines and use thereof as polymer stabilizers
03/26/2013US8404728 Small-molecule botulinum toxin inhibitors
03/26/2013US8404722 Oxazole compounds compositions and methods of use
03/26/2013US8404708 Dual NK1/NK3 receptor antagonists
03/26/2013US8404693 Substituted piperidine compounds and methods of their use
03/26/2013US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
03/26/2013US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors
03/26/2013US8404676 Oxadiazole diaryl compounds
03/26/2013US8404672 Substituted heterocyclic compounds
03/26/2013CA2531485C Malonamide derivatives
03/21/2013WO2013040044A1 Aminopyrimidine derivatives for use as modulators of kinase activity
03/21/2013WO2013039202A1 Novel acrylic acid derivative
03/21/2013WO2013039140A1 Fused heterocyclic derivative
03/21/2013WO2013038386A1 Heterocyclic compounds for the treatment of cystic fibrosis
03/21/2013WO2013037755A1 Plant growth regulating compounds
03/21/2013WO2013037731A1 Novel polymorphic form of raltegravir potassium
03/21/2013WO2013037721A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/21/2013WO2013037717A1 Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives
03/21/2013WO2013037704A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/21/2013WO2013037703A1 3 -pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents
03/21/2013WO2012157984A3 Novel heteroaromatic compounds and use thereof
03/21/2013US20130072680 Processes for the preparation of rivaroxaban and intermediates thereof
03/21/2013US20130072679 Dihydroquinoline-2-one derivatives
03/21/2013US20130072677 Novel hydroxamic acid derivative
03/21/2013US20130072523 Analogues for the treatment or prevention of flavivirus infections
03/21/2013US20130072494 Inhibitors of jun n-terminal kinase
03/21/2013US20130072490 Polycyclic compounds as lysophosphatidic acid receptor antagonists
03/21/2013US20130072489 Triazole compounds that modulate hsp90 activity
03/21/2013US20130072488 Aralkyl diamine derivatives and uses thereof as antidepressants
03/21/2013US20130072487 Prolyl hydroxylase inhibitors
03/21/2013US20130072486 Pyrimidine cyclohexyl glucocorticoid receptor modulators
03/21/2013US20130072480 Cyclothiocarbamate Derivatives as Progesterone Receptor Modulators
03/21/2013US20130072478 N-(3-(2-amino-6,6-difluoro-4,4a,5,6,7,7a-hexahydro-cyclopenta[e][1,3]oxazin-4-yl)-phenyl-amides as bace1 inhibitors
03/21/2013US20130072469 Heteroaryl compounds and uses thereof
03/21/2013US20130072468 Substituted piperazines as cb1 antagonists
03/21/2013US20130072461 Triazole compounds that modulate hsp90 activity
03/21/2013US20130072457 Pyrazolyl quinazoline kinase inhibitors
03/21/2013US20130072449 Lysophosphatidic acid receptor antagonists
03/21/2013CA2846779A1 Plant growth regulating compounds
03/21/2013CA2844865A1 3-pyridine carboxylic acid hydrazides as hdl-cholesterol raising agents
03/21/2013CA2844835A1 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/21/2013CA2844834A1 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/21/2013CA2844704A1 Aminopyrimidine derivatives for use as modulators of kinase activity
03/20/2013EP2569313A1 Compounds useful as inhibitors of atr kinase
03/20/2013EP2569312A1 Substituted heterocyclyl benzyl pyrazoles, and use thereof
03/20/2013EP2569311A1 Ambipolar small molecule hosts for phosphorescent guest emitters
03/20/2013EP2569310A1 Morpholine compounds as mineralocorticoid receptor antagonists
03/20/2013EP2569309A1 Hydroxyalkyl benzyl pyrazoles, and use thereof for the treatment of hyperproliferative and angiogenic diseases
03/20/2013EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
03/20/2013EP2569305A1 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
03/20/2013EP2569301A1 Indazole inhibitors of kinase
03/20/2013EP2569300A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
03/20/2013EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
03/20/2013EP2569291A1 Selective glycosidase inhibitors and uses thereof
03/20/2013EP2569287A2 Compounds useful as inhibitors of atr kinase
03/20/2013EP2569285A1 Bifunctional quinoline derivatives
03/20/2013EP2569284A1 2 -aminopyridine derivatives useful as inhibitors of atr kinase
03/20/2013EP2569280A1 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
03/20/2013EP2125795B1 Indole derivatives
03/20/2013CN1606554B Beta-lactamyl vasopressin v1a antagonists
03/20/2013CN102985419A Fungicide hydroximoyl-heterocycles derivatives
03/20/2013CN102985407A 8-hydroxy-quinoline derivatives
03/20/2013CN102977087A Application of selective alpha2A receptor stimulant in treating alzheimer disease
03/20/2013CN102977086A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
03/20/2013CN102977085A 2-aryl-benzo[d]oxazole and 2-aryl-benzo[d]thiazole derivatives, and preparation methods and application thereof
03/20/2013CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs
03/20/2013CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/20/2013CN102101852B Coumarin derivates, preparation method thereof and application thereof in white-light organic electroluminescent device
03/20/2013CN102030743B Iloperidone crystal, and preparation method and medicinal composition thereof
03/20/2013CN101466709B 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity
03/20/2013CN101039920B 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
03/19/2013US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
03/19/2013US8399673 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators
03/19/2013US8399666 5-lipoxygenase-activating protein (FLAP) inhibitors
03/19/2013US8399660 Process for the synthesis of triazoles
03/19/2013US8399497 Thiazole derivatives and use thereof
03/19/2013US8399493 Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
03/19/2013US8399463 Imidazole derivatives
03/19/2013US8399461 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same
03/19/2013US8399460 Chromenone derivatives
03/19/2013US8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors
03/19/2013US8399451 Heterocyclic compounds
03/19/2013US8399450 Compounds and compositions as protein kinase inhibitors
03/19/2013US8399448 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
03/19/2013US8399436 N-pyrazolyl carboxamides as CRAC channel inhibitors
03/19/2013US8399433 Amino pyrimidine anticancer compounds
03/19/2013CA2682629C Pyrimidine hydrazide compounds as pgds inhibitors
03/19/2013CA2549228C Hiv protease inhibiting compounds
03/19/2013CA2524027C Immunosuppressant compounds and compositions
03/19/2013CA2319465C Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/14/2013WO2013036671A1 Compounds useful for treating neurodegenerative disorders
03/14/2013WO2013036207A1 Derivatives of xanthone compounds
03/14/2013WO2013036196A1 Novel thiophene compounds and method for in vivo imaging
03/14/2013WO2013035827A1 Novel olefin derivative
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 647